Deunoxavir Marboxil
- Generic Name
- Deunoxavir Marboxil
Safety and Efficacy of ADC189 in Children 2-11 Years Old With Influenza
Phase 3
Recruiting
- Conditions
- Influenza Type AInfluenza Type B
- Interventions
- Drug: ADC189 tabletsDrug: Placebo of Baloxavir Marboxil tabletsDrug: Placebo of ADC189 tabletsDrug: Placebo of ADC189 granules
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Jiaxing AnDiCon Biotech Co.,Ltd
- Target Recruit Count
- 165
- Registration Number
- NCT06507813
- Locations
- 🇨🇳
Beijing Children's Hospital,Capital Medical University, Beijing, Beijing, China
To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Jiaxing AnDiCon Biotech Co.,Ltd
- Target Recruit Count
- 16
- Registration Number
- NCT06485401
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, China
Comparative Bioavailability Study of Tablet and Granule Formulations of ADC189 and the Study of Ultra-high Dose
Phase 1
Completed
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2025-01-20
- Lead Sponsor
- Jiaxing AnDiCon Biotech Co.,Ltd
- Target Recruit Count
- 48
- Registration Number
- NCT06428903
- Locations
- 🇨🇳
Zhao Wei, Jinan, Shang Dong, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath